Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to determine whether the water-soluble contrast (gastrografin) is more effective in the treatment of postoperative ileus than the conventional one.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospital Universitari de Bellvitge
NCT05334485 · Postoperative Ileus
NCT07271875 · Postoperative Gastrointestinal Dysfunction (POGD), Postoperative Ileus, and more
NCT03143621 · Postoperative Ileus
NCT03772444 · Postoperative Ileus
NCT04675606 · Ileostomy; Complications, Bowel Obstruction, and more
Hospital Universitari de la Vall d´Hebron
Barcelona, Barcelona
Hospital Universitari Bellvitge
L'Hospitalet de Llobregat, Barcelona
Hospital Universitari de Girona
Girona, Girona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions